Patents by Inventor Yuqiang SHEN

Yuqiang SHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Laser fusion welding device
    Patent number: 11938567
    Abstract: A laser fusion welding device includes a 1.9 ?m laser light source, a control unit and a light spot adjusting device. The control unit is configured to control the laser light source and the light spot adjusting device to adjust a laser power density at an object to be subjected to fusion welding. The 1.9 ?m laser light source has output power of 100-500 W. The control unit includes a time control unit, a power control unit and a light spot control unit. The time control unit is configured to control a turn-on time of the laser light source. The power control unit is configured to control the output power of the laser light source. The light spot control unit is configured to control the light spot adjusting device to adjust a size of a light spot at the object to be subjected to fusion welding.
    Type: Grant
    Filed: July 11, 2023
    Date of Patent: March 26, 2024
    Assignee: XINJIANG TECHNICAL INSTITUTE OF PHYSICS AND CHEMISTRY, CHINESE ACADEMY OF SCIENCES
    Inventors: Linjun Li, Shilie Pan, Xiaoming Duan, Yu Zhou, Yingjie Shen, Qianqian Hao, Yuqiang Yang, Xin He
  • ANTI-OX40 ANTIBODY AND USE THEREOF
    Publication number: 20230061604
    Abstract: Provided are an anti-OX40 antibody, a composition including the anti-OX40 antibody, a nucleic acid encoding the anti-OX40 antibody, a method for preparing the anti-OX40 antibody, and a use of the anti-OX40 antibody.
    Type: Application
    Filed: December 28, 2020
    Publication date: March 2, 2023
    Inventors: Hongkai Zhang, Yuan Wang, Yun-Yueh Lu, Yuqiang Shen, Nicola Arturo Aldo Beltraminelli, Liang Schweizer, Francisco Adrian, Klaus Andreas Raue, Qian Zhang, Jinping Gan
  • ANTIBODIES BINDING CTLA-4 AND USES THEREOF
    Publication number: 20220002414
    Abstract: Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.
    Type: Application
    Filed: July 14, 2021
    Publication date: January 6, 2022
    Applicant: Harbour BioMed (Shanghai) Co., Ltd.
    Inventors: Xin GAN, Yun HE, Yuqiang SHEN, Jiuqiao ZHAO, Yiping RONG, Frank Grosveld, Dubravka Drabek, Marinus (Rien) Van Haperen, Rick Janssens
  • Antibodies binding CTLA-4 and uses thereof
    Patent number: 11098122
    Abstract: Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: August 24, 2021
    Assignee: HARBOUR BIOMED (SHANGHAI) CO., LTD.
    Inventors: Xin Gan, Yun He, Yuqiang Shen, Jiuqiao Zhao, Yiping Rong, Frank Grosveld, Dubravka Drabek, Marinus (Rien) Van Haperen, Rick Janssens
  • ANTIBODIES BINDING CTLA-4 AND USES THEREOF
    Publication number: 20190202914
    Abstract: Disclosed are isolated monoclonal antibodies, comprising a CD152-binding domain, wherein the antibodies bind specifically to human CD152. Methods of making and using the antibodies to treat diseases including cancers and autoimmune diseases are also provided.
    Type: Application
    Filed: December 19, 2018
    Publication date: July 4, 2019
    Inventors: Xin GAN, Yun HE, Yuqiang SHEN, Jiuqiao ZHAO, Yiping RONG